Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2869)
All Articles published online
|
Jun 15, 2004 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1726.htm |
| Number | Citing Articles |
| 1 |
Sabrina J. Ritch, BreeAnn N. Brandhagen, Alicia A. Goyeneche, Carlos M. Telleria. Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5587-3
|
| 2 |
Monserrat Llaguno-Munive, Mario Romero-Piña, Janeth Serrano-Bello, Luis Medina, Norma Uribe-Uribe, Ana Salazar, Mauricio Rodríguez-Dorantes, Patricia Garcia-Lopez. Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma. Cancers 2018; 11(1): 16 doi: 10.3390/cancers11010016
|
| 3 |
Mary Lander. The fight for a life‐saving drug: a personal perspective. Medical Journal of Australia 2007; 187(11-12): 706 doi: 10.5694/j.1326-5377.2007.tb01488.x
|
| 4 |
Jianzhong Chen, Jichuang Wang, Jingwei Shao, Yu Gao, Jianguo Xu, Suhong Yu, Zhenhua Liu, Lee Jia. The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis. Medicinal Research Reviews 2014; 34(5): 979 doi: 10.1002/med.21311
|
| 5 |
Monserrat Llaguno-Munive, Luis Alberto Medina, Rafael Jurado, Mario Romero-Piña, Patricia Garcia-Lopez. Mifepristone improves chemo-radiation response in glioblastoma xenografts. Cancer Cell International 2013; 13(1) doi: 10.1186/1475-2867-13-29
|
| 6 |
BreeAnn N Brandhagen, Chelsea R Tieszen, Tara M Ulmer, Maria S Tracy, Alicia A Goyeneche, Carlos M Telleria. Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-35
|
| 7 |
Qing Chang, Renyi Qin, Tao Huang, Jun Gao, Yanping Feng. Effect of Antisense Hypoxia-inducible Factor 1?? on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer. Pancreas 2006; 32(3): 297 doi: 10.1097/00006676-200604000-00010
|
| 8 |
İlhan Elmaci, Meric A. Altinoz, Aydin Sav, Zeliha Yazici, Aysel Ozpinar. Giving another chance to mifepristone in pharmacotherapy for aggressive meningiomas—A likely synergism with hydroxyurea?. Current Problems in Cancer 2016; 40(5-6): 229 doi: 10.1016/j.currproblcancer.2016.05.001
|
| 9 |
Ji Hoon Jang, Kyoung-jin Min, Shin Kim, Jong-Wook Park, Taeg Kyu Kwon. RU486 Induces Pro-Apoptotic Endoplasmic Reticulum Stress Through the Induction of CHOP Expression by Enhancing C/EBPδ Expression in Human Renal Carcinoma Caki Cells. Journal of Cellular Biochemistry 2016; 117(2): 361 doi: 10.1002/jcb.25278
|
| 10 |
Stacy L. Wempe, Carlos D. Gamarra-Luques, Carlos M. Telleria. Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer Cells. Cancer Growth and Metastasis 2013; 6: CGM.S11124 doi: 10.4137/CGM.S11124
|
| 11 |
Jichuang Wang, Jianzhong Chen, Liyuan Wan, Jingwei Shao, Yusheng Lu, Yewei Zhu, Minrui Ou, Suhong Yu, Haijun Chen, Lee Jia. Synthesis, Spectral Characterization, and In Vitro Cellular Activities of Metapristone, a Potential Cancer Metastatic Chemopreventive Agent Derived from Mifepristone (RU486). The AAPS Journal 2014; 16(2): 289 doi: 10.1208/s12248-013-9559-2
|
| 12 |
Huo Xu, Liyuan Wan, Jianguo Xu, Jian Liu, Ning Zheng, Lee Jia. HAMPT, A Novel Quadruple Drug Combination Designed for Cancer Metastatic Chemoprevention: From Hypothesis to Proof-of-concept. Current Cancer Drug Targets 2019; 19(4): 296 doi: 10.2174/1568009618666181001102557
|
| 13 |
Chunlian Zhong, Yusheng Lu, Yumei Li, Huanzhang Xie, Guiyu Zhou, Lee Jia. Similarities and differences between embryonic implantation and CTC invasion: Exploring the roles of abortifacients in cancer metastasis chemoprevention. European Journal of Medicinal Chemistry 2022; 237: 114416 doi: 10.1016/j.ejmech.2022.114416
|
| 14 |
Chih-Wei Tsao, Jia-Sin Li, Ya-Wen Lin, Sheng-Tang Wu, Tai-Lung Cha, Chin-Yu Liu. Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3′-diindolylmethane in an enzalutamide-resistant prostate cancer cell line. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80519-3
|
| 15 |
Sabrina J. Ritch, Abu Shadat M. Noman, Alicia A. Goyeneche, Carlos M. Telleria. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02822-5
|
| 16 |
Jing Wang, Jian Chen, Kailiang Zhang, Yuan Zhao, Jacques E. Nör, Junzheng Wu. TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells. Journal of Oral Pathology & Medicine 2011; 40(10): 762 doi: 10.1111/j.1600-0714.2011.01051.x
|
| 17 |
Alicia A Goyeneche, Carlos M Telleria. Antiprogestins in gynecological diseases. REPRODUCTION 2015; 149(1): R15 doi: 10.1530/REP-14-0416
|